- Home
- FLS vs ASND Comparison
FLS vs ASND Comparison
Compare FLS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLS
- ASND
- Stock Information
- Founded
- FLS 1790
- ASND 2006
- Country
- FLS United States
- ASND Denmark
- Employees
- FLS N/A
- ASND N/A
- Industry
- FLS Fluid Controls
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- FLS Industrials
- ASND Health Care
- Exchange
- FLS Nasdaq
- ASND Nasdaq
- Market Cap
- FLS 8.3B
- ASND 9.1B
- IPO Year
- FLS N/A
- ASND 2015
- Fundamental
- Price
- FLS $42.31
- ASND $158.14
- Analyst Decision
- FLS Strong Buy
- ASND Strong Buy
- Analyst Count
- FLS 10
- ASND 15
- Target Price
- FLS $64.30
- ASND $202.00
- AVG Volume (30 Days)
- FLS 1.8M
- ASND 562.0K
- Earning Date
- FLS 04-29-2025
- ASND 05-05-2025
- Dividend Yield
- FLS 1.99%
- ASND N/A
- EPS Growth
- FLS 50.70
- ASND N/A
- EPS
- FLS 2.14
- ASND N/A
- Revenue
- FLS $4,557,806,000.00
- ASND $376,478,932.00
- Revenue This Year
- FLS $6.94
- ASND $61.43
- Revenue Next Year
- FLS $4.72
- ASND $73.07
- P/E Ratio
- FLS $19.70
- ASND N/A
- Revenue Growth
- FLS 5.49
- ASND 36.34
- 52 Week Low
- FLS $37.34
- ASND $111.09
- 52 Week High
- FLS $65.08
- ASND $169.37
- Technical
- Relative Strength Index (RSI)
- FLS 40.55
- ASND 55.10
- Support Level
- FLS $39.85
- ASND $153.17
- Resistance Level
- FLS $43.68
- ASND $165.42
- Average True Range (ATR)
- FLS 2.70
- ASND 10.68
- MACD
- FLS 0.19
- ASND 1.20
- Stochastic Oscillator
- FLS 46.58
- ASND 82.40
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. In addition, Flowserve has a network of Quick Response Centers to provide aftermarket equipment services. The aftermarket services help customers with installation, diagnostics, repair, and retrofitting. Sales are roughly split across many regions, with North America and Europe contributing the majority of total revenue.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.